← All science articles

· 2 min read

Mice Show Distinct Antibody Patterns to Synthetic Double-Stranded RNA Complex

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

This 1984 study in Clinical and Experimental Immunology looked at how mice respond immunologically to a synthetic double-stranded RNA molecule called poly(G) . poly(C), made by pairing two synthetic ribonucleic acid strands (guanylic acid and cytidylic acid). Gaffiero and colleagues immunized ten inbred mouse strains with this complex and measured antibody production.

The mice fell into high responders (strains SJL/J and BALB/c), low responders (DBA/2 and AKR), and intermediate responders. This pattern held whether or not the molecule was attached to a carrier protein (MBSA) and after one or several injections; the resulting antibodies were found in the 7S region, a size class of antibody molecules. Compared with two other synthetic double-stranded RNA complexes, poly(A) . poly(U) and poly(I) . poly(C), and with single-stranded DNA, the immune response to poly(G) . poly(C) followed its own distinct pattern — antibodies against it could also bind poly(A) . poly(U), though no clear link between the two reactivities emerged.

This is a basic immunology study in mice using synthetic nucleic acids, not DNA fragments from a natural source and not a human or skin study. It cannot show anything about therapeutic use, wound healing, or skin effects; it is limited to characterizing how the mouse immune system distinguishes between different synthetic nucleic acid structures, with a passing note that related antibodies also appear in lupus patients.

Our reflection

This paper sits far from today's skin and wound applications of PDRN, but it belongs to the broader foundation of nucleic-acid immunology that the field later built on — understanding how the immune system recognizes different nucleic acid structures. At Havdis, we see value in tracing this long arc of basic science, even when a given study's direct relevance to modern applications is limited.

Source

Gaffiero GV, Robin P, Nahon E (1984). Clinical and experimental immunology.

Read the paper on PubMedFree full text (PMC)

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.